Abstract
Objective: The goal of this succinct case report and literature analysis is to shed light on the symptoms, diagnosis, course, and outcomes of COVID-19-associated neuropathy. Method: An instance of chronic peripheral neuropathy that developed after a COVID-19 infection is presented. Neurologists, infectious disease experts, and rehabilitation specialists are involved in the diagnostic workup and multidisciplinary management detailed here. An in-depth analysis of the literature on COVID-19-related neuropathy was performed. Results: Following COVID-19, the patient continued to experience symptoms of peripheral neuropathy. Diagnostic testing confirmed neuropathy. Medication, rehabilitation, and supportive care were all part of the treatment. The review of the literature added knowledge about pathophysiology, diagnostics, and therapeutic strategies. Conclusion: Neuropathy brought on by COVID-19 is a significant clinical problem. This brief report emphasizes the ongoing peripheral neuropathy caused by COVID-19. The thorough management strategy and literature review improve comprehension of the diagnosis and course of action. Early detection is crucial for the best results.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
